Bevacizumab Injection 400 Mg
Bevacizumab Injection 400 Mg

Bevacizumab Injection 400 Mg

MOQ : 50 Vials

Bevacizumab Injection 400 Mg Specification

  • Brand Name
  • Bevacizumab (varies by manufacturer, e.g., Avastin, Bevacirel, Bryxta, etc.)
  • Pacakaging (Quantity Per Box)
  • Usually 1 vial per box
  • Salt Composition
  • Bevacizumab 400 mg
  • Dosage Form
  • Parenteral
  • Packaging Type
  • Vial
  • Origin of Medicine
  • Imported or Indian manufacture (varies)
  • Life Span
  • 18-24 months (see manufacturers expiry)
  • Indication
  • For use in metastatic or recurrent cancer treatment as indicated
  • Drug Type
  • Prescription only, biological product
  • Ingredients
  • Bevacizumab
  • Physical Form
  • Injection
  • Function
  • Anti-cancer (anti-angiogenic agent)
  • Recommended For
  • Cancer treatment, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and others as prescribed
  • Dosage
  • 400 mg per vial
  • Dosage Guidelines
  • As directed by the oncologist or prescribing physician
  • Suitable For
  • Adults
  • Quantity
  • 1 vial
  • Storage Instructions
  • Store in a refrigerator (2C - 8C). Do not freeze. Protect from light.
  • Contraindications
  • Hypersensitivity to Bevacizumab or excipients, pregnancy, certain cardiovascular conditions
  • Adverse Effects
  • Hypertension, bleeding, proteinuria, impaired wound healing, gastrointestinal perforations, thromboembolism
  • Regulatory Status
  • US FDA and DCGI approved (product-specific)
  • Therapeutic Class
  • Antineoplastic agents - monoclonal antibodies
  • Administration Route
  • Intravenous infusion, diluted prior to administration
  • Shelf Life After Opening
  • Use immediately after dilution. If not, store diluted solution for up to 24 hours at 2C - 8C.
  • Mechanism of Action
  • Monoclonal antibody that inhibits VEGF (Vascular Endothelial Growth Factor), preventing angiogenesis
  • Preservative Free
  • Yes
  • Caution
  • Use with caution in patients with history of cardiovascular disease
  • Dilution Instructions
  • Must be diluted with 0.9% sodium chloride solution before use
  • Clinical Use
  • Administered under medical supervision in hospital or clinical setting
  • Appearance
  • Clear to slightly opalescent, colorless to pale brown solution
  • Prescription Status
  • Rx only
  • Reconstitution Required
  • No, but requires dilution before administration
 

Bevacizumab Injection 400 Mg Trade Information

  • Minimum Order Quantity
  • 50 Vials
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Vials Per Month
  • Delivery Time
  • 2-10 Days
  • Main Domestic Market
  • All India
 

About Bevacizumab Injection 400 Mg



Discover the new, cost-effective Bevacizumab Injection 400 Mg, a crackerjack solution for advanced cancer care. This formidable, opulent monoclonal antibody works by inhibiting VEGF, preventing angiogenesis and tumor growth. Customizable dosing ensures tailored therapy per oncologist's direction. Each preservative-free vial contains a clear to pale brown solution, requiring no reconstitution but mandatory dilution before IV infusion. Approved by US FDA and DCGI, it is suitable for various cancers, including metastatic colorectal and non-small cell lung cancer. Storage and administration guidelines ensure optimal efficacy and safety.

Unlock Powerful Cancer Care: Usage & Competitive Edge

Bevacizumab Injection 400 Mg is indicated for the management of metastatic or recurrent cancers, including colorectal, lung, and brain tumors. Its anti-angiogenic mechanism curtails tumor blood supply with precision. Usage requires dilution in saline and intravenous infusion by healthcare professionals. Competitive advantages include proven clinical efficacy, customizable regimens, and approval by major health authorities. This solution is a formidable addition to the therapeutic arsenal, delivering reliable outcomes, enhanced safety, and exceptional adaptability for adult cancer patients.


Sample Policy, Certifications & Export Markets

Estimate sample dispatch and goods transport timelines by contacting our support team. Samples of Bevacizumab Injection 400 Mg are provided under strict clinical guidelines. The product holds recognized certifications, including US FDA and DCGI approval. Our main export markets encompass Asia, Africa, the Middle East, and other regions seeking advanced oncology solutions. Rely on us for timely exports and compliant documentation, ensuring your procurement process for this opulent monoclonal antibody meets global standards.


FAQ's of Bevacizumab Injection 400 Mg:


Q: How should Bevacizumab Injection 400 Mg be administered?

A: Bevacizumab Injection should be administered as an intravenous infusion after diluting it with 0.9% sodium chloride solution, under the supervision of a qualified healthcare professional.

Q: What are the recommended storage conditions for this product?

A: The injection should be stored in a refrigerator at 2C to 8C, protected from light, and should not be frozen. Use the diluted solution within 24 hours if stored at 2C to 8C.

Q: When is Bevacizumab Injection indicated for use?

A: It is recommended for treatment of metastatic or recurrent cancers including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and other types as prescribed by an oncologist.

Q: Where can this injection be administered?

A: Bevacizumab Injection is administered under strict medical supervision, usually in a hospital or clinical setting with appropriate monitoring.

Q: What are the main benefits of Bevacizumab Injection 400 Mg?

A: Main advantages include a formidable, targeted anti-cancer action, customizable dosing, and regulatory approval for multiple cancer indications, making it suitable for a variety of adult patients.

Q: How is the product packaged and supplied?

A: Each vial contains 400 mg of Bevacizumab and is supplied as a single vial per box, usually imported or manufactured in India, depending on brand availability.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Injection Category

Ertapenem 1gm Injection

Ertapenem 1gm Injection

Minimum Order Quantity : 50 Boxes

Ingredients : Ertapenem Sodium Equivalent to Ertapenem 1g

Indication : Complicated intraabdominal infections, communityacquired pneumonia, complicated urinary tract infections, skin and soft tissue infections, pelvic infections, prophylaxis of surgical site infection in colorectal surgery

Suitable For : Other, Suitable for vegetarians and nonvegetarians

Dosage Guidelines : Administer intravenously or intramuscularly under medical supervision

Drug Type : Other, Generic

Levosimendan Injection 12.5mg

Levosimendan Injection 12.5mg

Minimum Order Quantity : 50 Vials

Ingredients : Levosimendan 12.5 mg

Indication : Acute decompensated severe chronic heart failure

Suitable For : Adults

Dosage Guidelines : Intravenous infusion, as prescribed

Drug Type : Other, Allopathic

Targocid 400 Mg Injection

Targocid 400 Mg Injection

Minimum Order Quantity : 50 Vials

Ingredients : Teicoplanin

Indication : Serious infections caused by susceptible Grampositive bacteria

Suitable For : Other, Adults and children, as prescribed

Dosage Guidelines : Follow medical advice or prescription

Drug Type : Other, Allopathic

750 mg Ferric Carboxymaltose Injection

750 mg Ferric Carboxymaltose Injection

Minimum Order Quantity : 50 Vials

Ingredients : Ferric Carboxymaltose 750 mg

Indication : Treatment of iron deficiency when oral iron preparations are ineffective or cannot be used.

Suitable For : Adults

Dosage Guidelines : Administer intravenously as per medical advice.

Drug Type : Other, Allopathic



Back to top